People | March 23, 2022
Lonza appoints Christian Seufert as President of CHI Division
Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses
Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses
The expansion makes Exothera one of the largest viral vector facilities in Europe
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
Enables millions of Indians to monitor their vitals without the need of any additional device
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab
Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships
Successful proposals will secure fully funded postdoctoral research positions
First approved in 2019, Rinvoq is a JAK inhibitor approved for four indications across gastroenterology, dermatology and rheumatology
DASH enables non-laboratory personnel to insert a nasal swab specimen directly into our test cartridge and then load the cartridge into the DASH instrument, providing an accurate result in about 15 minutes
Subscribe To Our Newsletter & Stay Updated
